Added to YB: 2025-07-30
Pitch date: 2025-07-28
HVO.L [neutral]
hVIVO plc
-47.4%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
Market Cap
GBP 67.2M
Pitch Price
GBP 0.10
Price Target
N/A
Dividend
2.02%
EV/EBITDA
2.20
P/E
6.37
EV/Sales
0.54
Sector
Life Sciences Tools and Services
Category
value
Monday Delight: 28/07/25 - hVIVO plc
HVO.L (quick overview): UK clinical research leader in human challenge trials (HCTs) for respiratory/infectious diseases. 22.3% ROCE, 2.9x EV/EBIT. HCTs de-risk failed clinical trials & accelerate FDA approvals for pharma clients. Market leader with expanded London facility. Potentially strong competitive position at bargain valuation.
Read full article (1 min)